Mikara Robati

665 total citations
11 papers, 511 citations indexed

About

Mikara Robati is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Mikara Robati has authored 11 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Mikara Robati's work include Cell death mechanisms and regulation (7 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Mikara Robati is often cited by papers focused on Cell death mechanisms and regulation (7 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Mikara Robati collaborates with scholars based in Australia, Germany and United Kingdom. Mikara Robati's co-authors include Philippe Bouillet, Andreas Strasser, Suzanne Cory, Cassandra J. Vandenberg, Stefan Glaser, Marc Pellegrini, Gayle M. Davey, Gabrielle T. Belz, W. Douglas Fairlie and David C.S. Huang and has published in prestigious journals such as The Journal of Experimental Medicine, Genes & Development and Blood.

In The Last Decade

Mikara Robati

10 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mikara Robati Australia	9	357	164	162	63	59	11	511
Hanako Daino Japan	10	326 0.9×	153 0.9×	174 1.1×	59 0.9×	52 0.9×	11	486
Valeria Cambiaghi Italy	9	335 0.9×	168 1.0×	126 0.8×	85 1.3×	30 0.5×	10	520
Kerstin Maria Kampa-Schittenhelm Germany	12	283 0.8×	171 1.0×	90 0.6×	155 2.5×	80 1.4×	30	516
Parham Ramezani-Rad United States	9	262 0.7×	105 0.6×	263 1.6×	124 2.0×	97 1.6×	19	615
Emma Arriola United Kingdom	7	276 0.8×	170 1.0×	81 0.5×	75 1.2×	70 1.2×	9	465
Ryan A. Denu United States	10	270 0.8×	155 0.9×	76 0.5×	98 1.6×	55 0.9×	24	502
Gina M. Ney United States	12	273 0.8×	82 0.5×	102 0.6×	58 0.9×	28 0.5×	19	438
Eduardo Sotomayor United States	7	244 0.7×	183 1.1×	301 1.9×	43 0.7×	32 0.5×	11	532
Laura Quotti Tubi Italy	10	275 0.8×	114 0.7×	52 0.3×	118 1.9×	98 1.7×	21	411
María Inmaculada Hernández Netherlands	4	367 1.0×	193 1.2×	175 1.1×	59 0.9×	15 0.3×	4	527

Countries citing papers authored by Mikara Robati

Since Specialization

Citations

This map shows the geographic impact of Mikara Robati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikara Robati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikara Robati more than expected).

Fields of papers citing papers by Mikara Robati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikara Robati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikara Robati. The network helps show where Mikara Robati may publish in the future.

Co-authorship network of co-authors of Mikara Robati

This figure shows the co-authorship network connecting the top 25 collaborators of Mikara Robati. A scholar is included among the top collaborators of Mikara Robati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikara Robati. Mikara Robati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Nguyen, Hai V., Cassandra J. Vandenberg, Mikara Robati, Ashley P. Ng, & Suzanne Cory. (2023). MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis. Cell Death and Differentiation. 30(4). 1018–1032.

Nguyen, Hai V., Cassandra J. Vandenberg, Ashley P. Ng, et al.. (2020). Development and Survival of MYC-driven Lymphomas Requires MYC-Antagonist MNT to Curb MYC-induced Apoptosis. Blood. 135(13). 1019–1031. 18 indexed citations

Mensink, Mark, Natasha S. Anstee, Mikara Robati, et al.. (2018). Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells. Cell Death and Differentiation. 25(4). 797–808. 15 indexed citations

Anstee, Natasha S., Rebecca A. Bilardi, Ashley P. Ng, et al.. (2018). Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice. Cell Death and Differentiation. 26(7). 1316–1331. 35 indexed citations

Bilardi, Rebecca A., Natasha S. Anstee, Stefan Glaser, et al.. (2016). Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice. Cell Death and Disease. 7(9). e2351–e2351. 6 indexed citations

Kelly, Gemma L., Stephanie Grabow, Stefan Glaser, et al.. (2014). Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53. Genes & Development. 28(1). 58–70. 126 indexed citations

Mérino, Delphine, Thomas Nebl, Frédérick Masson, et al.. (2012). Alternative splicing of Bim and Erk-mediated BimEL phosphorylation are dispensable for hematopoietic homeostasis in vivo. Cell Death and Differentiation. 19(6). 1060–1068. 33 indexed citations

Mérino, Delphine, Seong Lin Khaw, Stefan Glaser, et al.. (2012). Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. Blood. 119(24). 5807–5816. 160 indexed citations

Hughes, Peter, Mikara Robati, Lu W, et al.. (2005). Loss of PKD1 and loss of Bcl-2 elicit polycystic kidney disease through distinct mechanisms. Cell Death and Differentiation. 13(7). 1123–1127. 11 indexed citations

10.

Pellegrini, Marc, Philippe Bouillet, Mikara Robati, et al.. (2004). Loss of Bim Increases T Cell Production and Function in Interleukin 7 Receptor–deficient Mice. The Journal of Experimental Medicine. 200(9). 1189–1195. 99 indexed citations

11.

Bouillet, Philippe, Mikara Robati, Jerry M. Adams, & Andreas Strasser. (2003). Loss of pro‐apoptotic BH3‐only Bcl‐2 family member bim does not protect mutant Lurcher mice from neurodegeneration. Journal of Neuroscience Research. 74(5). 777–781. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact